Average Co-Inventor Count = 4.40
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neurogen Corporation (19 from 305 patents)
2. Amgen Inc. (10 from 1,974 patents)
3. Biovitrum Ab (3 from 55 patents)
4. Pfizer Corporation (1 from 4,455 patents)
30 patents:
1. 8686011 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
2. 8642624 - Substituted alkylamine derivatives and methods of use
3. 8541592 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
4. 7807700 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
5. 7662811 - 1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use
6. 7642267 - Benzimidazole and pyridylimidazole derivatives
7. 7612060 - Triazoles and methods of use
8. 7371752 - Aryl fused substituted 4-oxy-pyridines
9. 7300945 - Benzimidazole and pyridylimidazole derivatives
10. 7253196 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11. 7101868 - Substituted arylamine derivatives and methods of use
12. 6995162 - Substituted alkylamine derivatives and methods of use
13. 6921762 - Substituted indolizine-like compounds and methods of use
14. 6916819 - Benzimidazole and pyridylimidazole derivatives
15. 6828329 - Aryl fused substituted 4-oxy-pyridines